Compile Data Set for Download or QSAR
maximum 50k data
Found 239 of ph data with Target = 'Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform'
LigandPNGBDBM21034((1R,3R,5S,6S,18S)-6-hydroxy-18-(methoxymethyl)-1,5...)
Affinity DataIC50:  2.70nMpH: 7.5 T: 2°CAssay Description:Inhibition of PI3K enzyme activity is measured in a microtiter plate-based fluorescence polarization (FP) assay. More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM25028(4-[2-(1H-indazol-4-yl)-6-[(4-methanesulfonylpipera...)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM25021(3-{6-[(dimethylamino)methyl]-4-(morpholin-4-yl)thi...)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM25022(3-(6-{[(2-methoxyethyl)(methyl)amino]methyl}-4-(mo...)
Affinity DataIC50:  4nMpH: 7.5 T: 2°CAssay Description:Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM15234((1R,3R,5S,9R,18S)-18-(methoxymethyl)-1,5-dimethyl-...)
Affinity DataIC50:  4.20nMpH: 7.4 T: 2°CAssay Description:Ptdlns 3-kinase enzyme activity was assayed by its converting Ptdlns(4,5)P2 into PtdIns(3,4,5)P3 in the presence of radioactive ATP. After reaction,...More data for this Ligand-Target Pair
LigandPNGBDBM25019(3-[6-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimid...)
Affinity DataIC50:  6nMpH: 7.5 T: 2°CAssay Description:Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM21036((2R,3S,6Z,14S,15S,17R)-6-({[3-(dimethylamino)propy...)
Affinity DataIC50:  6.40nMpH: 7.5 T: 2°CAssay Description:Inhibition of PI3K enzyme activity is measured in a microtiter plate-based fluorescence polarization (FP) assay. More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM25024(3-(6-{[4-(2-hydroxyethyl)piperazin-1-yl]methyl}-4-...)
Affinity DataIC50:  7nMpH: 7.5 T: 2°CAssay Description:Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM25018(3-(4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)phe...)
Affinity DataIC50:  8nMpH: 7.5 T: 2°CAssay Description:Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM21039((2R,3S,6Z,14S,15S,17R)-6-({tert-butyl[2-(dimethyla...)
Affinity DataIC50:  9.60nMpH: 7.5 T: 2°CAssay Description:Inhibition of PI3K enzyme activity is measured in a microtiter plate-based fluorescence polarization (FP) assay. More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM25023(3-{6-[(4-methylpiperazin-1-yl)methyl]-4-(morpholin...)
Affinity DataIC50:  10nMpH: 7.5 T: 2°CAssay Description:Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM25020(3-[7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimid...)
Affinity DataIC50:  21nMpH: 7.5 T: 2°CAssay Description:Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM25027(4-[2-(1H-indazol-4-yl)-6-[(4-methylpiperazin-1-yl)...)
Affinity DataIC50:  44nMpH: 7.5 T: 2°CAssay Description:Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM21040((2R,3S,6Z,14S,15S,17R)-6-({benzyl[2-(dimethylamino...)
Affinity DataIC50:  66nMpH: 7.5 T: 2°CAssay Description:Inhibition of PI3K enzyme activity is measured in a microtiter plate-based fluorescence polarization (FP) assay. More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM21035((2R,3S,6E,15S,17R)-6-{[bis(prop-2-en-1-yl)amino]me...)
Affinity DataIC50:  88nMpH: 7.5 T: 2°CAssay Description:Inhibition of PI3K enzyme activity is measured in a microtiter plate-based fluorescence polarization (FP) assay. More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM15234((1R,3R,5S,9R,18S)-18-(methoxymethyl)-1,5-dimethyl-...)
Affinity DataIC50:  99nMpH: 7.4 T: 2°CAssay Description:The luminescence-based kinase assay with recombinant phosphatidylinositol 3-kinase (Upstate Cell Signaling Solutions) was used for the determination ...More data for this Ligand-Target Pair
LigandPNGBDBM25025(4-[2-(1H-indazol-4-yl)thieno[3,2-d]pyrimidin-4-yl]...)
Affinity DataIC50:  102nMpH: 7.5 T: 2°CAssay Description:Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM226282(US9321790, 94)
Affinity DataIC50:  130nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM25082(3-(2,4-diamino-pteridin-6-yl)-phenol | 3-(2,4-diam...)
Affinity DataIC50:  165nMpH: 7.4 T: 2°CAssay Description:The luminescence-based kinase assay with recombinant phosphatidylinositol 3-kinase (Upstate Cell Signaling Solutions) was used for the determination ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM226283(US9321790, 95)
Affinity DataIC50:  180nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM226271(US9321790, 83)
Affinity DataIC50:  190nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM226272(US9321790, 84)
Affinity DataIC50:  200nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM226266(US9321790, 78)
Affinity DataIC50:  250nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM226299(US9321790, 111)
Affinity DataIC50:  330nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM226270(US9321790, 82)
Affinity DataIC50:  340nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM226305(US9321790, 117)
Affinity DataIC50:  380nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM21026((2R,3S,6Z,14S,15S,17R)-6-[(diethylamino)methyliden...)
Affinity DataIC50:  382nMpH: 7.5 T: 2°CAssay Description:Inhibition of PI3K enzyme activity is measured in a microtiter plate-based fluorescence polarization (FP) assay. More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM251598(US9453031, 21)
Affinity DataIC50:  400nMpH: 7.5 T: 2°CAssay Description:The kinase activity was measured by using the commercial ADP Hunter Plus assay available from DiscoveRx (#33-016), which is a homogeneous assay to me...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM21030((2R,3S,6Z,14S,15S,17R)-6-{[tert-butyl(methyl)amino...)
Affinity DataIC50:  440nMpH: 7.5 T: 2°CAssay Description:Inhibition of PI3K enzyme activity is measured in a microtiter plate-based fluorescence polarization (FP) assay. More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM226285(US9321790, 97)
Affinity DataIC50:  440nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM226289(US9321790, 101)
Affinity DataIC50:  450nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM226280(US9321790, 92)
Affinity DataIC50:  450nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM251623(US9453031, 46)
Affinity DataIC50:  480nMpH: 7.5 T: 2°CAssay Description:The kinase activity was measured by using the commercial ADP Hunter Plus assay available from DiscoveRx (#33-016), which is a homogeneous assay to me...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM21033((2R,3S,6Z,14S,15S,17R)-8,14-dihydroxy-3-(methoxyme...)
Affinity DataIC50:  496nMpH: 7.5 T: 2°CAssay Description:Inhibition of PI3K enzyme activity is measured in a microtiter plate-based fluorescence polarization (FP) assay. More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM226303(US9321790, 115)
Affinity DataIC50:  590nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM21032((2R,3S,6Z,14S,15S,17R)-6-{[butyl(methyl)amino]meth...)
Affinity DataIC50:  635nMpH: 7.5 T: 2°CAssay Description:Inhibition of PI3K enzyme activity is measured in a microtiter plate-based fluorescence polarization (FP) assay. More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM21038((2R,3S,6Z,14S,15S,17R)-6-({[3-(dimethylamino)propy...)
Affinity DataIC50:  638nMpH: 7.5 T: 2°CAssay Description:Inhibition of PI3K enzyme activity is measured in a microtiter plate-based fluorescence polarization (FP) assay. More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM251593(US9453031, 16)
Affinity DataIC50:  670nMpH: 7.5 T: 2°CAssay Description:The kinase activity was measured by using the commercial ADP Hunter Plus assay available from DiscoveRx (#33-016), which is a homogeneous assay to me...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM226260(US9321790, 72)
Affinity DataIC50:  730nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM226281(US9321790, 93)
Affinity DataIC50:  780nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM226259(US9321790, 71)
Affinity DataIC50:  810nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM226262(US9321790, 74)
Affinity DataIC50:  820nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM226265(US9321790, 77)
Affinity DataIC50:  820nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM251635(US9453031, 72)
Affinity DataIC50:  820nMpH: 7.5 T: 2°CAssay Description:The kinase activity was measured by using the commercial ADP Hunter Plus assay available from DiscoveRx (#33-016), which is a homogeneous assay to me...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM226291(US9321790, 103)
Affinity DataIC50:  840nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM251633(US9453031, 70)
Affinity DataIC50:  870nMpH: 7.5 T: 2°CAssay Description:The kinase activity was measured by using the commercial ADP Hunter Plus assay available from DiscoveRx (#33-016), which is a homogeneous assay to me...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM226292(US9321790, 104)
Affinity DataIC50:  930nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM226264(US9321790, 76)
Affinity DataIC50:  950nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM226258(US9321790, 70)
Affinity DataIC50:  1.00E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM226213(US9321790, 25)
Affinity DataIC50:  1.00E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 239 total ) | Next | Last >>
Jump to: